Clinical Trials Logo

Recurrent Primary Peritoneal Cancer clinical trials

View clinical trials related to Recurrent Primary Peritoneal Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT01970722 Recruiting - Clinical trials for Stage IV Ovarian Cancer

Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer

Start date: May 2014
Phase: Phase 1
Study type: Interventional

This clinical trial studies the side effects and how well surgery and heated chemotherapy with or without non-heated chemotherapy after surgery works in treating patients with ovarian, fallopian tube, uterine, or peritoneal cancer. Giving a dose of heated chemotherapy into the abdomen during surgery that is done to remove ovarian, fallopian tube, uterine, or peritoneal cancer may help lower the risk of the cancer coming back. Giving unheated chemotherapy drugs directly into the abdomen after surgery may kill more tumor cells.

NCT ID: NCT01853644 Recruiting - Clinical trials for Recurrent Fallopian Tube Cancer

Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Start date: May 2013
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well tivozanib works in treating patients with recurrent ovarian, fallopian tube, or primary peritoneal cancer. Tivozanib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.